Compare Cassava Sciences Inc (FLNA) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Matson Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Matson Inc trades at $204.7 (market cap $6.11B). The key difference: Matson Inc is far larger — about 128× Cassava Sciences Inc's market cap, and Matson Inc pays a 0.74% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | MATX | |
|---|---|---|
Market Cap | $47.75M | $6.11B |
Sector | Health | Technology |
52-Week High | $4.64 | $223.55 |
52-Week Low | $0.87 | $88.05 |
Enterprise Value | -$34.93M | $6.71B |
Dividend Yield | — | 0.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
